Pure Global

Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes - Trial NCT05777720

Access comprehensive clinical trial information for NCT05777720 through Pure Global AI's free database. This phase not specified trial is sponsored by Stanford University and is currently Enrolling by invitation. The study focuses on Covid19. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05777720
Enrolling by invitation
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05777720
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes
A Cluster-randomized Controlled Trial of Air Filtration and Ventilation Improvements to Reduce SARS CoV 2 Transmission Among Household Contacts

Study Focus

Covid19

Filtration Fan

Interventional

device

Sponsor & Location

Stanford University

San Mateo,Stanford, United States of America

Timeline & Enrollment

N/A

Jan 30, 2023

Jun 01, 2024

200 participants

Primary Outcome

Incidence of Covid19

Summary

Investigators are evaluating whether an intervention consisting of box-fans with MERV 16
 filters (filtration fans) and recommendations for improving ventilation in the home can
 reduce secondary spread of Covid19 from an index case to susceptible contacts within the
 home.

ICD-10 Classifications

COVID-19, virus identified
COVID-19, virus not identified
Coronavirus infection, unspecified site
Rift Valley fever
Plague

Data Source

ClinicalTrials.gov

NCT05777720

Device Trial